Hope for stargardt patients: new drug aims to slow vision loss
NCT ID NCT07419334
First seen Feb 28, 2026 · Last updated May 25, 2026 · Updated 11 times
Summary
This study tests an investigational drug called gildeuretinol acetate (ALK 001) in 230 people aged 8 to 45 with Stargardt disease, an inherited condition that causes progressive vision loss. The goal is to see if the drug can slow the growth of damage in the retina and help preserve sight over 24 months. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor the study team will know which they receive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STARGARDT DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Associated Retina Consultants
RECRUITINGPhoenix, Arizona, 85020, United States
Contact
Contact Email: •••••@•••••
-
Erie Retina Research
RECRUITINGErie, Pennsylvania, 16505, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vitreo Retinal Associates
NOT_YET_RECRUITINGGainesville, Florida, 32607, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.